Canada Issues License for Cartagenia Bench Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Bioinformatics company Cartagenia today announced it received a Canadian medical establishment license for its Cartagenia Bench platform.

The platform is a cloud-based software product for the analysis, interpretation, reporting, and sharing of genomic variants in routine clinical diagnostics. It is CE marked, registered with the US Food and Drug Administration as an exempt Class I Medical Device, and registered in Europe also as a Class I Medical Device, Cartagenia said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.